Arizona State Retirement System’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-10,649
| Closed | -$100K | – | 2145 |
|
2024
Q4 | $100K | Buy |
10,649
+146
| +1% | +$1.37K | ﹤0.01% | 2089 |
|
2024
Q3 | $84.7K | Buy |
10,503
+307
| +3% | +$2.47K | ﹤0.01% | 2127 |
|
2024
Q2 | $86.5K | Sell |
10,196
-68
| -0.7% | -$577 | ﹤0.01% | 2070 |
|
2024
Q1 | $92.1K | Sell |
10,264
-1,548
| -13% | -$13.9K | ﹤0.01% | 2088 |
|
2023
Q4 | $133K | Sell |
11,812
-2,177
| -16% | -$24.5K | ﹤0.01% | 2059 |
|
2023
Q3 | $121K | Sell |
13,989
-218
| -2% | -$1.88K | ﹤0.01% | 2040 |
|
2023
Q2 | $147K | Sell |
14,207
-433
| -3% | -$4.48K | ﹤0.01% | 2031 |
|
2023
Q1 | $159K | Sell |
14,640
-1,534
| -9% | -$16.6K | ﹤0.01% | 2003 |
|
2022
Q4 | $181K | Buy |
16,174
+661
| +4% | +$7.42K | ﹤0.01% | 1956 |
|
2022
Q3 | $157K | Buy |
15,513
+534
| +4% | +$5.4K | ﹤0.01% | 1978 |
|
2022
Q2 | $136K | Buy |
14,979
+38
| +0.3% | +$345 | ﹤0.01% | 2050 |
|
2022
Q1 | $143K | Buy |
14,941
+110
| +0.7% | +$1.05K | ﹤0.01% | 2088 |
|
2021
Q4 | $164K | Buy |
14,831
+126
| +0.9% | +$1.39K | ﹤0.01% | 2134 |
|
2021
Q3 | $109K | Buy |
14,705
+2,531
| +21% | +$18.8K | ﹤0.01% | 2168 |
|
2021
Q2 | $177K | Sell |
12,174
-864
| -7% | -$12.6K | ﹤0.01% | 2143 |
|
2021
Q1 | $266K | Buy |
13,038
+144
| +1% | +$2.94K | ﹤0.01% | 1881 |
|
2020
Q4 | $229K | Sell |
12,894
-431
| -3% | -$7.66K | ﹤0.01% | 1879 |
|
2020
Q3 | $197K | Buy |
13,325
+3,447
| +35% | +$51K | ﹤0.01% | 1785 |
|
2020
Q2 | $207K | Sell |
9,878
-116
| -1% | -$2.43K | ﹤0.01% | 1636 |
|
2020
Q1 | $231K | Buy |
+9,994
| New | +$231K | ﹤0.01% | 1440 |
|